Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
850.00    34.00 (4.17%)
Bid:
844.00
Ask:
852.00
Spread: 8.00 (0.948%)
Market Cap: £391.82m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Acquisition

5 Apr 2017 07:00

RNS Number : 5869B
Porvair PLC
05 April 2017
 



For immediate release 5 April 2017

 

 

Porvair plc

 

Acquisition

 

Porvair ("the Group"), the specialist filtration and environmental technologies group, announces the acquisition of J. G. Finneran Associates, Inc. ("JGF").  JGF, based in Vineland, New Jersey, designs, manufactures and distributes specialist laboratory consumables including filters, vials, microplates, closures and ancillary products.

On 4 April 2017, Porvair acquired 100% of the issued share capital of JGF and its related freehold property from the Finneran family ("the Acquisition").

The initial consideration for the Acquisition is $8.0m, payable in cash, with a further deferred cash payment of up to a maximum of $6.0m, payable in the years ending 30 November 2018 and 2019, subject to the satisfaction of certain growth targets during the years ending 31 March 2018 and 2019. The Acquisition is expected to be earnings enhancing in its first full year of ownership.

The Board sees a good fit between JGF and Porvair's already established life science and biotechnology activities. JGF brings manufacturing capabilities and strong US distribution to the Group. Together the businesses have a broad product offering for chromatography, sample preparation and environmental laboratories. Opportunities exist for combining manufacturing and marketing activities. 

The Board is pleased to welcome the Finneran family and JGF staff to the Porvair Group.

 

For further information, please contact:

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Stephanie Watson

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration markets, and are derived from its expertise in the design and manufacture of filtration systems using ceramic, metal, plastic and carbon media. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (EU) No. 596/2014

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQOKQDBABKDKQK
Date   Source Headline
26th Jun 20137:00 amRNSDirectors' Shareholdings and Issue of Equity
24th Jun 20136:17 pmRNSHolding(s) in Company
24th Jun 20137:00 amRNSInterim Results
21st Jun 20139:02 amRNSBlocklisting application
5th Jun 20137:00 amRNSAcquisition and Trading Update
31st May 201312:01 pmRNSTotal Voting Rights
16th Apr 20134:02 pmRNSDirectors' Shareholdings and Issue of Equity
16th Apr 20132:39 pmRNSAGM resolutions and notice of filings
16th Apr 20137:00 amRNSAGM Statement, IMS and Contract extension
28th Feb 201310:00 amRNSTotal Voting Rights
13th Feb 20137:00 amRNSContract Win
5th Feb 20136:16 pmRNSHolding(s) in Company
5th Feb 20134:40 pmRNSHolding(s) in Company
28th Jan 201312:28 pmRNSBlocklisting Application
28th Jan 20137:00 amRNSResults for the year ended 30 November 2012
11th Jan 20137:00 amRNSContract Win
30th Nov 20128:48 amRNSHolding(s) in Company
29th Nov 201211:32 amRNSHolding(s) in Company
29th Nov 201210:29 amRNSDirector/PDMR Shareholding
28th Nov 20127:00 amRNSPre-close trading update
28th Sep 201212:34 pmRNSDirector/PDMR Shareholding
26th Sep 20127:00 amRNSInterim Management Statement
2nd Aug 20127:00 amRNSDirectorate Change
12th Jul 20129:38 amRNSDirector/PDMR Shareholding
26th Jun 20127:00 amRNSInterim Results
24th May 20127:00 amRNSTrading Update
19th Apr 20127:00 amRNSDirector/PDMR Shareholding
18th Apr 20127:00 amRNSAcquisition of Pulse Instrumentation
11th Apr 20123:57 pmRNSResult of AGM
11th Apr 20127:00 amRNSAGM Statement and IMS
7th Mar 20129:21 amRNSPosting of Annual Report and Accounts
5th Mar 20127:00 amRNSAcquisition
2nd Mar 201211:54 amRNSTotal Voting Rights
31st Jan 20127:00 amRNSPreliminary Results
30th Dec 20117:00 amRNSTotal Voting Rights
8th Dec 20119:21 amRNSHolding(s) in Company
6th Dec 20117:00 amRNSPre-close trading update and acquisition
30th Nov 20117:00 amRNSTotal Voting Rights
23rd Nov 20117:00 amRNSContract win
7th Nov 20114:44 pmRNSAnnual Information Update
4th Nov 20112:57 pmRNSTotal Voting Rights
26th Oct 20118:20 amRNSHolding(s) in Company
6th Oct 20117:00 amRNSChange in Director's details
5th Oct 20112:30 pmRNSNotification of Major Interest in Shares
5th Oct 20112:24 pmRNSNotification of Major Interest in Shares
4th Oct 20117:00 amRNSIssue of equity and Directors' shareholdings
21st Sep 20117:00 amRNSDirectors' Dealing
20th Sep 20117:00 amRNSInterim Management Statement
31st Aug 20116:07 pmRNSHolding(s) in Company
31st Aug 20116:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.